GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 92 filers reported holding GRITSTONE ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $30,000 | +3.4% | 11,809 | -2.1% | 0.00% | 0.0% |
| Q2 2022 | $29,000 | -42.0% | 12,064 | 0.0% | 0.00% | -25.0% |
| Q1 2022 | $50,000 | -67.7% | 12,064 | 0.0% | 0.00% | -60.0% |
| Q4 2021 | $155,000 | +19.2% | 12,064 | 0.0% | 0.01% | +11.1% |
| Q3 2021 | $130,000 | +18.2% | 12,064 | 0.0% | 0.01% | +12.5% |
| Q2 2021 | $110,000 | -12.7% | 12,064 | -9.4% | 0.01% | -20.0% |
| Q1 2021 | $126,000 | +12.5% | 13,314 | -53.1% | 0.01% | +11.1% |
| Q4 2020 | $112,000 | +28.7% | 28,380 | -13.3% | 0.01% | +12.5% |
| Q3 2020 | $87,000 | -64.0% | 32,740 | -10.0% | 0.01% | -68.0% |
| Q2 2020 | $242,000 | +160.2% | 36,390 | +127.0% | 0.02% | +127.3% |
| Q1 2020 | $93,000 | -35.4% | 16,030 | 0.0% | 0.01% | -26.7% |
| Q4 2019 | $144,000 | – | 16,030 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,561,150 | $9,152,000 | 15.60% |
| Frazier Life Sciences Management, L.P. | 5,237,348 | $13,460,000 | 1.04% |
| Redmile Group, LLC | 6,952,760 | $17,869,000 | 0.69% |
| Palo Alto Investors LP | 2,330,504 | $5,989,000 | 0.47% |
| ACT CAPITAL MANAGEMENT, LLC | 47,500 | $122,000 | 0.17% |
| SkyOak Wealth, LLC | 132,851 | $341,000 | 0.12% |
| Artal Group S.A. | 750,000 | $1,928,000 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 77,046 | $198,000 | 0.04% |
| CAXTON ASSOCIATES LP | 95,190 | $245,000 | 0.03% |
| XTX Topco Ltd | 50,517 | $130,000 | 0.03% |